Monday, January 22, 2018


mid rising tension between drug makers and compound pharmacies, the Food and Drug Administration has issued new policies 1 that seek to bolster manufacturing standards for compounded medicines and, in the process, may serve to establish competitive boundaries between
Post a Comment